Introduction
Diamond Blackfan anemia (DBA) and Shwachman Diamond syndrome (SDS) are congenital bone marrow failure syndromes linked to defects in ribosome synthesis and/or function.
1 DBA and SDS are also characterized by a heterogeneous collection of congenital anomalies and a predisposition to cancer. Although both diseases share these general features, there are substantial differences in their clinical manifestations. DBA is characterized by a red blood cell hypoplasia, whereas SDS is frequently characterized by neutropenia, although other hematopoietic lineages may also be affected in both disorders. Patients with SDS also display exocrine pancreatic deficiency, which is not observed in DBA. 2 The congenital anomalies in SDS include short stature, skeletal defects and neurological problems. Patients with DBA also have short stature, but in contrast to SDS, craniofacial anomalies are the most commonly associated congenital malformations along with other abnormalities, including triphalangeal thumbs and genitourinary tract and cardiac defects. 3, 4 Both diseases carry an increased risk of cancer, however, they differ in neoplastic potential and types of malignancies. Approximately 30-40% of SDS patients progress to myelodysplastic syndrome (MDS) and/or acute myelogenous leukemia (AML). DBA has a lower cancer incidence affecting approximately 2% of the patient population. Both solid tumors and blood-based cancers have been observed in DBA patients. 4 The molecular underpinnings of both DBA and SDS converge on a common target, the ribosome. To date, the genes involved in DBA all encode structural components of the ribosome. Three of these genes, RPS17, RPS19 and RPS24 encode ribosomal proteins of the 40S subunit. [5] [6] [7] More recently, RPL5, RPL11, and RPL35A genes encoding 60S subunit ribosomal proteins have been shown to harbor pathogenic mutations in DBA. 8, 9 Several studies have shown that ribosomal proteins affected in DBA are required for the maturation of ribosomal subunits indicating that the basis for the clinical features of DBA resides in abortive ribosome synthesis. [8] [9] [10] [11] [12] In SDS, the gene affected is SBDS, which encodes a protein associated with 60S ribosomal subunits (13) . SBDS is not a structural component of the ribosome. The yeast ortholog of SBDS, Sdo1, has been reported to be required for the biogenesis and function of the 60S ribosomal subunit.
14 In contrast, there have been conflicting reports regarding the role for SBDS in the biogenesis of 60S ribosomal subunits in mammalian cells. 13 While these data indicate that both DBA and SDS may arise through defects in ribosome synthesis and/or function, little is known regarding how these changes in this common target result in their distinct clinical presentations.
Studies in animal models of DBA have recently shown that the tumor suppressor p53 plays an important role in developmental and hematological phenotypes. [15] [16] [17] These results are generally interpreted in the context of a model wherein some form of nucleolar stress signaling promotes p53 stabilization and activation. 18 Two pathways appear ideally suited to signal features of abortive ribosome assembly to growth control and apoptosis. Both involve MDM2, a zinc-finger ubiquitin ligase, which targets p53 for proteasomal degradation. Several ribosomal proteins have now been shown to bind to MDM2 and inhibit its ubiquitin ligase activity resulting in p53 stabilization and activation. 19 In this model, ribosomal proteins are liberated from productive assembly into ribosomal subunits and are free for signaling through MDM2. Alternatively, nucleolar stress can also signal through the ARF tumor suppressor.
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This latter pathway appears to involve nucleophosmin, a nucleolar protein recently shown to be involved in ribosome trafficking from the nucleus to the cytoplasm.
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The recent discoveries of genes encoding 60S subunit ribosomal proteins mutated in DBA has allowed us to focus on the large ribosomal subunit as a common target in yeast models for DBA and SDS. 8, 9 These models employed yeast strains mutated in RPL33A, the yeast ortholog of RPL35A mutated in DBA, 8 and SDO1, the ortholog of SBDS mutated in SDS. 22 Our goal was to determine if there are molecular features that differentiate the two disease models. Here we show that both models affect the production of 60S subunits, but do so by distinct mechanisms which affect different stages of the subunit maturation pathway. The subunit deficit in the DBA model is linked to an assembly defect that results in immature particles that are rapidly degraded. This assembly defect is associated with a substantial increase in the amount of extra-ribosomal 5S rRNA. This observation is intriguing in light of the observation that, in mammalian cells, ribosomal proteins Rpl5 and Rpl11, in complex with 5S rRNA, interact with MDM2 and promote p53 stabilization and activation. 23 In contrast to the data obtained for the DBA model, the subunit deficit in the SDS model is linked to defects later in the subunit maturation pathway. As a consequence of this rather late maturation defect a significant fraction of the 60S subunit precursors found in the SDS model are retained within the nucleoplasm associated with 5S rRNA. Thus, the two disease models differ dramatically in terms of their effects on subunit assembly and the potential for subsequent diversion of ribosomal components from their normal assembly pathway to potential interactions with other growth regulatory factors within cells. These models therefore provide a mechanistic basis for how differing effects on 60S subunit maturation could potentially trigger alternative signaling pathways within cells that give rise to the distinct clinical phenotypes of DBA and SDS.
Design and Methods

Yeast strains
The yeast strains used in this study were generated by the Polysome profiling, Northern hybridization, and pulse-chase analyses Cell extracts were prepared for polysome analysis as outlined previously. 24 Centrifugation was carried out at 28,000 RPM for 6 hours in an SW28.1 rotor (Beckman Instruments, Inc., Fullerton, CA, USA). Sucrose gradients were fractionated and the absorbance at 254nm monitored using an ISCO model 185 gradient fractionator (Teledyne Isco, Inc., Lincoln, NE, USA) interfaced to a UA-6 absorbance detector. RNA was recovered from sucrose gradient fractions after precipitation with 2 volumes of absolute ethanol. Precipitates were collected by centrifugation for 10 minutes at 10,000xg. Precipitates were suspended in 0.3 ml of 20 mM Tris-HCl pH 7.4, 2.5 mM EDTA, 100 mM NaCl, and 1% SDS. Suspensions were extracted twice with phenol/chloroform and RNA in the aqueous phase was precipitated overnight at -20°with 2.5 volumes of ethanol. RNA was washed once with 70% ethanol, dried in vacuo, and suspended in DEPC-treated water. RNA was fractionated on 1.5% formaldehyde-agarose gels, transferred to ζ-probe, and hybridized with oligonucleotides labeled at their 5' ends with 32 [P]. Oligonucleotides were radio-labeled using polynucleotide kinase and γ-
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[P]-ATP. Oligonucleotides employed were: 5S rRNA probe 5'-CAGTTGATCGGACGGGAACA-3', 5.8S rRNA probe 5'-CGTATCGCATTTCGCTGCGTTC-3', and C2-ITS2 probe 5?-GGCCAGCAATTTCAAGTTA-3'. Procedures for pulse-chase analysis were described previously. 24 Data were scanned and digitized using Adobe Photoshop.
Live cell fluorescence imaging
Yeast strains were transformed with PRS316-RPL25eGFP (URA3) and pUN100-DsRed-NOP1 (LEU2) vectors using an Alkali-Cation™ Yeast Kit (Qbiogene, inc., Carlsbad, CA, USA) as directed by the manufacturer. Isolated transformants were grown to mid-log phase in synthetic complete liquid media lacking leucine and uracil. 1 mL aliquots were then taken and centrifuged at 10,000 RPM for 15 seconds to pellet the cells. The supernatant was discarded and the resulting pellet was washed with 0.5 mL of KPO4/sorbitol wash solution (1.2M sorbitol, 0.1M potassium phosphate, pH 7.5). Cell pellets were then resuspended in 300 µL of KPO4/sorbitol wash solution and 1 µL of 10 µg/ml 4',6-diamidino-2-phenylindole nuclear stain (DAPI) added. Cell/DAPI suspensions were incubated at room temperature for 10 minutes. Following this incubation period, cells were washed twice with KPO4/sorbitol solution, re-suspended in 200 µL of KPO4/sorbitol, and 2.5 µL of this cell suspension added to glass microscope slides. Cells were then subjected to fluorescent imaging using a Zeiss Axiovert 200 multi-channel fluorescence microscope (Carl Zeiss MicroImaging, Inc., Thornwood, NY, USA).
Results
Yeast strains heterozygous for RPL33A and SDO1 deletions were obtained from Euroscarf or Research Genetics. The diploid strains were sporulated, tetrads dissected, and resulting haploid progeny grown on rich media. Cells harboring either deletion had a pronounced growth deficit compared with wild-type (data not shown). To assess the effect of the RPL33A and SDO1 deletions on the steady-state level of 60S subunits, extracts were prepared in low magnesium buffer where polysomes and 80S monosomes dissociate completely into 40S and 60S ribosomal subunits. The ratio of 60S to 40S subunits was used to examine the selective effect of these mutations on 60S subunit levels beyond any overall reduction in ribosome synthesis linked to reduced growth rate. Figure 1 shows both yeast models exhibit a reduction in the quantity of 60S subunits relative to 40S subunits when compared to wild-type. The relative reduction of 60S subunits in the two mutant strains differed by approximately 10% with the ∆RPL33A showing the greater overall reduction.
Pulse-chase analysis of pre-rRNA processing was used for a more detailed characterization of subunit maturation in the DBA and SDS disease models. The yeast pre-rRNA processing pathway is shown in Figure 2A . Relative to wild-type, the RPL33A mutant showed a pronounced delay in the production of mature 25S rRNA such that by 10 minutes of chase the amount of radio-label in 25S rRNA relative to 18S rRNA was significantly less than the approximate 2/1 ratio observed in wild-type cells ( Figure 2B top panel). This selective effect on 25S rRNA synthesis was accompanied by delayed maturation of several pre-rRNA precursors including 35S, 23S, and 27S pre-rRNAs. The delayed maturation of 35S and 23S pre-rRNAs was the result of an ill-defined feedback system where early steps in prerRNA processing are slowed in mutants that affect the maturation of 60S subunits. 25 The delayed maturation of 27S pre-rRNA species, on the other hand, accounted for the selective effect of the ∆RPL33A mutant on the maturation of 60S subunits. Figure 2B top panel shows a 27S pre-rRNA doublet that persisted through the 10 minute chase period. This doublet consisted of 27S A2/A3 species (upper band) and 27S B (lower band). The primary effect of the RPL33A deletion was a delay in maturation of 27S A2/A3 pre-rRNAs as evidenced by the increased ratio of 27S A2/A3 to 27S B pre-rRNA observed by Northern analysis ( Figure 2C ). The data from the ∆SDO1 strain, on the other hand, revealed a more complex effect on 60S subunit maturation. Like the ∆RPL33A strain, there was a delay in 35S and 23S pre-rRNA processing, consistent with the feedback effect of a reduction in 60S subunits on early steps in pre-rRNA processing. The persistence of 35S and 23S pre-rRNAs in the ∆SDO1 strain indicates that cleavage steps A0 and A1 involved in the maturation of the 5? end of 18S rRNA may be more adversely affected when compared with the ∆RPL33A strain. Moreover, there was clearly a delay in 27S B pre-rRNA processing apparent by pulse-chase analysis in the ∆SDO1 mutant relative to wild-type ( Figure 2B , bottom panel) and also observed by Northern analysis ( Figure 2C) . Surprisingly, however, the effect of this delay on the production of 25S rRNA did not appear to be as great as that observed in the ∆RPL33A strain since the ratio of 25S to 18S rRNA in this strain was still greater than 1.
A more comprehensive analysis of the protein synthetic apparatus in the two disease models was examined by polysome analysis. Polysome profiles from the ∆RPL33A strain showed a marked reduction in free 60S subunits relative to wild-type and the appearance of half-mer polysomes ( Figure 3 , middle panel). Half-mer polysomes are polysomes with stalled 48S initiation complexes and are a common characteristic of yeast strains with a deficit of 60S subunits. 26 The polysome profiles from the ∆SDO1 strain also exhibited half-mer polysomes, but in contrast to the ∆RPL33A strain, there was a significant pool of free 60S subunits and a noteworthy decrease in mean polysome size (Figure 3 , bottom panel). These data differ from previously reported polysome data from SDO1 mutants where neither half- Figure 1 . Yeast models of DBA and SDS both exhibit deficits in the relative amount of 60S to 40S ribosomal subunits. Extracts prepared for subunit analysis were prepared as described for polysome isolation except magnesium was omitted from the buffers. Ribosomal subunits were resolved on 7-47% stepwise sucrose gradients via centrifugation. Gradients were broken down and the absorbance at 254nm monitored using a gradient fractionator interfaced to a UA-6 absorbance detector. A radiolabeled oligonucleotide probe that hybridized to the C2 processing site located within internal transcribed spacer 2 (ITS2) was used for Northern analyses. Membranes were exposed to BioMax MS film at -80°using a BioMax LE intensifying screen or were subjected to phosphorimage analysis. mer polysomes nor a free pool of 60S subunits was observed.
14 Both mutant strains show a peak to the left of the 40S peak which is absent in the wild-type strain. This peak was shown to contain 20S RNA, an endogenous virus-like particle induced by various forms of translational stress.
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To evaluate the intracellular distribution of 60S subunits in the two disease models, 60S subunits were tracked using a GFP-Rpl25 fusion protein. Several studies have shown that this protein is assembled into 60S subunits and can be used to monitor their distribution within cells. In wild-type cells GFP fluorescence was distributed throughout nuclear and cytoplasmic regions but was reduced in intensity in the region corresponding to resident vacuoles (Figure 4, top panel) . In ∆RPL33A cells cytoplasmic GFP fluorescence intensity was diminished, with discrete regions of enhanced GFP fluorescence that coincided with Nop1 and DAPI staining ( Figure 4 , middle panel). Rpl33, like many yeast ribosomal proteins, is encoded by duplicated genes that are nearly identical. Therefore, the cytoplasmic staining within these cells presumably results from the incorporation of Rpl33B into 60S subunits. The nucleolar localized GFP fluorescence observed in the ∆RPL33A strain likely represents the modest accumulation of immature 60S subunits as a consequence of delayed pre-rRNA processing at sites A2 and A3. The overall reduction in GFP-Rpl25 staining in the ¢RPL33A strain relative to wild-type indicates that these immature precursors are subject to enhanced decay. In contrast, ∆SDO1 strains showed a pronounced accumulation of fluorescence in regions that broadly encompass Nop1 and DAPI staining and likely represent the retention of more fully matured 60S subunits in the nucleoplasm (Figure 4 , bottom panel). Given the relative reduction of 60S subunits in the ∆SDO1 strain observed by subunit profiles in Figure1, we believe a fraction of these more fully matured subunits accumulating in the absence of Sdo1 undergo degradation, albeit at a rate much reduced from that observed for immature subunits in the ∆RPL33A strain. Together, these data indicate that the defect in 60S subunit maturation between the two disease models occurs at a later step in the ∆SDO1 strain when compared with the ∆RPL33A strain, resulting in the accumulation of more fully matured precursors in the former relative to the latter.
Based on the emerging role for the 5S rRNA subcomplex in signaling abortive ribosome assembly to p53 activation in mammalian cells, we examined the fate of 5S rRNA in the yeast models of DBA and SDS. In wildtype cells, 5S rRNA was found in fractions corresponding to 60S subunits, 80S monosomes, and polysomes, with only a small fraction of extra-ribosomal 5S rRNA found near the top of the gradient ( Figure 5 ). In ¢RPL33A extracts there was a dramatic increase in the amount of extra-ribosomal 5S rRNA found near the top of the gradient (~ 41% of the total 5S RNA relative to 1 1% for wild-type), while in other regions of the gradient the amount of 5S rRNA was reduced. This latter observation is consistent with the absorbance tracings of the gradient profiles which showed an almost complete loss of free 60S subunits and a lower level of polysomes including half-mer polysomes, relative to wild-type ( Figure 3 ). Similar to the ∆RPL33A strain, extracts from the ∆SDO1 strain showed a significant reduction in the amount of 5S rRNA in the polysome region of the gradient compared to wild-type. In contrast to that of ∆RPL33A strain, ∆SDO1 extracts showed a substantial peak of 5S rRNA in the 60S region comparable to that of wild-type. The ratio of 5S to 5.8S rRNA in this peak was similar to that found in 80S and polysome regions indicating that this free pool of 60S subunits contains stoichiometric amounts of these two mature rRNA species. The increase in 5S rRNA in the 60S region in ∆SDO1 extracts was associated with a lower amount of extra-ribosomal 5S rRNA (~ 27% of total 5S RNA) found near the top of the gradient when compared with the ∆RPL33A strain. Thus, the two disease models differ dramatically in their effect on subunit assembly and stability including differences in the fate of 5S rRNA as a consequence of these distinct effects on 60S subunit maturation.
Discussion
The recent finding that DBA can be caused by mutations in genes encoding large subunit ribosomal proteins has a number of implications. 8, 9 This observation now suggests that any of the approximately 60 genes encoding large subunit ribosomal proteins could be mutated in DBA patients whose genetic lesion is unknown. Further, this observation continues to support the notion that DBA is caused by mutations in genes encoding structural components of the ribosome and that either subunit can be affected. For the purposes of the present study, the finding that 60S subunit ribosomal proteins are affected in DBA allowed for a more direct comparison of the underlying molecular bases for DBA and SDS, as the target in SDS also appears to be the 60S ribosomal subunit.
13,14
The yeast models of DBA and SDS examined here are both associated with a selective reduction in the amount of 60S ribosomal subunits. This reduction was more severe in ∆RPL33A extracts relative to ∆SDO1 extracts when total subunit analysis was performed. In both cases, the reduced amount of 60S subunits was associated with the appearance of half-mer polysomes upon polysome analysis. Half-mer polysomes are polysomes with stalled 48S initiation complexes generally linked to defects in 60S subunit synthesis.
26 In this case, subunit joining is delayed in forming 80S initiation complexes leaving 48S initiation complexes stalled at the initiation codon. The reduction in 60S subunits in the ∆RPL33A strain occurred at the level of 27S A2/A3 pre-rRNA processing, which resulted in delayed production of 27S B pre-rRNA and reduced amounts of mature 5.8S and 25S rRNAs. A related defect in the production of 60S ribosomal subunits has recently been demonstrated for a yeast strain harboring a missense mutation in RPL33A.
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In the yeast model of SDS, half-mer polysomes were observed in cells that still had a substantial pool of free 60S ribosomal subunits. These results differ dramatically from a previous report of an SDO1 deletion strain in which half-mer polysomes were not observed despite an apparent reduction in the amount of 60S subunits.
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These previous findings were difficult to explain since numerous studies have shown that a reduction in 60S subunits gives rise to half-mer polysomes. 25 Our data reveal that there is also a delay in pre-rRNA processing in the ∆SDO1 strain, but that this delay occurs at the level of 27S B pre-rRNA, downstream of the effect observed in cells depleted of Rpl33A. This delay is also associated with the retention of a significant fraction of 60S subunits within the nuclei of ∆SDO1 cells. Thus, the effect of the SDO1 mutation on the amount of 60S subunits available for translation in the cytoplasm represents a combined effect of both delayed pre-rRNA processing and nuclear retention. This interpretation is in general agreement with conclusions reached previously on the role of Sdo1 in recycling Tif6 from the cytoplasm to the nucleus where it is involved in 60S subunit maturation, but differs significantly from the previous report in the supporting data.
In comparing the two disease models we have shown that they differ in their effect on the maturation of 60S subunits ( Figure 6 ). Both 35S pre-rRNA and 5S rRNA are found in 90S pre-ribosomal particles assembled early in the ribosome maturation pathway. 29 The maturation defect in the DBA model occurs earlier in the pathway and is accompanied by the rapid degradation of incompletely assembled precursors. In contrast, the maturation defect in the SDS model is associated with delayed export, and accumulation of 60S-like particles in the nucleoplasm. The differences in the mechanism by which ribosome maturation is disrupted in these yeast models of DBA and SDS could therefore form the basis for different types of nucleolar/nuclear stress signaling and be responsible for their distinct clinical presentations in humans.
Accumulating data suggest that nucleolar stress signaling linked to abortive ribosome assembly plays an important role in the pathophysiology of DBA. Studies in zebra fish 16 and mouse 17 models of DBA suggest that p53 stabilization and activation promoted by nucleolar stress signaling is critical for phenotypes associated with ribosomal protein haploinsufficiency. While many potential mechanisms can explain p53 activation and stabilization under stress conditions, recent studies have identified mechanisms more specific to nucleolar stress induced by abortive ribosome assembly. 19, 30 Three large subunit ribosomal proteins have been shown to bind to MDM2 and promote p53 stabilization and activation. Two of these proteins, Rpl5 and Rpl11, have been shown to bind synergistically with MDM2, most likely mediated through their interaction with 5S rRNA. 23 We were therefore interested in following the fate of 5S rRNA in our yeast models of DBA and SDS in an effort to determine whether the maturation defects outlined above influenced 5S rRNA assembly.
Intriguingly, both disease models showed an increase in extra-ribosomal 5S rRNA relative to wild-type. 5S rRNA is distinct from the other 3 mature rRNA species in that 5S rRNA is transcribed by RNA polymerase III, distinct from the 35S polycistronic precursor transcribed by RNA polymerase I, which gives rise to 25S, 18S, and 5.8S rRNAs. 25 Moreover, 5S rRNA forms a subcomplex with Rpl5, Rpl11 and specific assembly factors within 60S subunit precursors. 29 Whether this subcomplex forms prior to joining 60S subunit precursors or after individual components of the subcomplexes are incorporated into maturing subunits has not been determined. 29 In the data reported here, the extra-ribosomal pool of 5S rRNA in wild-type cells accounts for only about 10% of the total 5S rRNA on sucrose gradients. This extra-ribosomal pool increases to approximately 40% of total 5S rRNA in ∆RPL33A extracts ( Figure 5 ). This increase could be a reflection of the inability of assembly intermediates lacking Rpl33A to stably incorporate components of the 5S rRNA subcomplex into 60S subunit precursors. The extent to which components of the 5S subcomplex depend on Rpl33A for incorporation into assembling 60S subunits is currently unknown (31) . The observation that depletion of Rpl33A blocks prerRNA processing upstream of 27S B pre-rRNA, which accumulates in cells depleted of components of the 5S subcomplex, 29, 32 is consistent with Rpl33A acting earlier in the pathway than components of the 5S subcomplex. We cannot, however, rule out the possibility that the increased extra-ribosomal 5S rRNA observed in cells depleted of Rpl33A results from the release of bound 5S subcomplex from abortive assembly intermediates targeted for degradation.
In contrast to the data obtained with the ∆RPL33A strain, our data show that 5S rRNA co-sediments with the large pool of free 60S subunits observed in ∆SDO1 cells. Our fluorescence data indicate that a considerable fraction of this pool of free 60S subunits in ∆SDO1 cells is retained within the nucleus. This pool of free 60S subunits likely represents pre-60S subunit precursors containing either 27S B pre-rRNA or pre-60S subunit precursors even further along the maturation pathway containing mature 25S and 5.8S rRNAs. 33 The ratio of 5S to 5.8S rRNAs in the free 60S subunit peak is similar to the ratio of 5S to 5.8S rRNAs in functional 60S subunits found in the polysome fractions, indicating that 5S rRNA has been incorporated into the nuclear-retained subunits in ∆SDO1 cells. The decreased amount of total 60S subunits in these cells suggests that this pool of pre-60S subunits may be turned over at a higher rate than mature 60S subunits that reach the cytoplasm. It is an interesting possibility that the increased amounts of extra-ribosomal 5S rRNA in ∆SDO1 strains is likely a consequence of the release of the 5S subcomplex from pre-60S particles targeted for degradation.
There are potential caveats to an integral role for com- ponents of the 5S rRNA subcomplex in signaling mechanisms that link abortive ribosome assembly to p53 stabilization and activation as a molecular basis for DBA pathophysiology. First is the general view that the assembly of 60S ribosomal subunits is largely independent of the assembly of 40S subunits, suggesting that haploinsufficiency for a small subunit ribosomal protein should not interfere with steps in 60S subunit assembly. Recent results from mammalian systems however, revealed that disruption of 40S subunit maturation resulted in an upregulation of translation of Rpl11.
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This upregulation presumably results in Rpl11 synthesized in excess of that needed for 60S subunit assembly which in turn, interacts with MDM2 leading to p53 activation. These studies did not however, address whether Rpl11 functioned in concert with other components of the 5S rRNA subcomplex in this signaling pathway. A second caveat with regard to a critical role for Rpl5 and Rpl11 signaling in DBA pathophysiology is the finding that RPL5 and RPL11 have both been identified as genes mutated in DBA. 9 Here it is difficult to envision how proteins that presumably limit ribosome assembly in an affected patient could also have an important role in signaling via an interaction with MDM2. The observation that patients with mutations in RPL5 have distinct clinical phenotypes suggests that alternative signaling pathways may operate in patients with mutations in RPL5 or RPL11.
Despite these caveats, we feel our yeast data support a potential role for the 5S ribonucleoprotein subcomplex in the pathogenesis of DBA. Moreover, the differences in the mechanisms by which 60S subunit maturation is affected in the DBA and SDS models and their influence on the 5S subcomplex suggest that this subcomplex may also be important in explaining how defects in the maturation of 60S ribosomal subunits can give rise to distinct clinical phenotypes.
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